---
title: "Association of Tumor-Localized TLS with Gene Expression Profile in Glioma Samples"
subtitle: "Group 21" 
author: 
  - Sai Renuka Chandrasekaran
  - Ole Lennart Decker
  - Raquel Ruiz Pascual
  - Parastoo Tabibzadehtehrani
  - Magdalena Zydorczak
format:
  revealjs:
    theme: serif
    slide-number: true
    center: false
    css: styles.css
    margin: 0.04
    embed-resources: true
    footer: ""
---

#### Introduction

**Study: "Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures"**^\[1\]^

::::: columns
::: {.column width="50%"}
![](images/Graphical_summary_article.png){fig-align="left" width="170cm" height="10cm"}
:::

::: {.column width="50%"}
Background:

-   Adult-type diffuse gliomas: "cold" tumors

-   Tertiary Lymphoid structures (TLSs)

Objectives:

-   Visualizing transcriptional patterns

-   Identifying key genes

-   Confirming TLS functionality
:::
:::::

::: footer[
<span style="font-size:0.5em;"> \[1\] Cakmak et al., 2025 – <a href="https://doi.org/10.1016/j.immuni.2025.09.018"> https://doi.org/10.1016/j.immuni.2025.09.018 </a>
:::

------------------------------------------------------------------------

#### Materials:

Dataset: GEO (NCBI) - GSE271059^\[2\]^ <br>

-   Metadata:

    -   IDH_status

    -   TLS_status

    -   Localisation

    -   Primary_or_Recurrent

    -   Age

    -   Gender

-   Raw data: gene expression count matrix (genes × samples)

<br>

<br>

::: footer[
[\[2\] GEO series GSE271059 – <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271059"> https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271059 </a>]{style="font-size:0.5em;"}
:::

------------------------------------------------------------------------

#### Methods

![](images/flow_chart_methods.drawio.png){width="80%"}

::: footer[
[\[3\] Ayers et al., 2017 – <a href="https://pubmed.ncbi.nlm.nih.gov/28650338/">https://pubmed.ncbi.nlm.nih.gov/28650338/</a>]{style="font-size:0.5em;"}
:::

------------------------------------------------------------------------

#### Results

##### Impact of TLS status on transcriptional signatures

::::: columns
::: {.column width="70%"}
![](images/TLS_status_PCA.png)
:::

::: {.column width="30%"}
-   TLS status does not strongly separate the samples

-   TLS group contains highly distinct outliers
:::
:::::

------------------------------------------------------------------------

#### Results

##### Impact of IDH status on transcriptional signatures

::::: columns
::: {.column width="70%"}
![](images/IDH_status_PCA.png)
:::

::: {.column width="30%"}
-   Clear and distinct separation of samples by IDH status

-   Outlier subsets exist
:::
:::::

------------------------------------------------------------------------

#### Results

##### TLS effect on gene expression

::::: columns
::: {.column width="70%"}
![](images/volcano_plot.png)
:::

::: {.column width="30%"}
-   Each point = one gene (TLS vs control)
-   Several genes are significantly associated with TLS status (q \< 0.05)
-   A large amount of genes are higher in TLS, others in controls
:::
:::::

------------------------------------------------------------------------

#### Results

##### GEP score by TLS status

::::: columns
::: {.column width="70%"}
![](images/GEP_score_vs_TLS_status.png)
:::

::: {.column width="30%"}
-   Each point = one tumor sample
-   GEP score (18-gene immune signature)
-   Median GEP score is higher in TLS tumors than in controls
:::
:::::

------------------------------------------------------------------------

#### Results

![](images/significant_genes_overlap.png){fig-align="center"}

::: {style="text-align: center;"}
Three genes were found to be TLS-significant
:::

------------------------------------------------------------------------

#### Discussion

-   PCA: TLS and control tumours largely overlap → TLS is not the main driver of variation.
-   PCA: clear separation by IDH status → strong impact of IDH mutations on expression.
-   PC1 + PC2 explain \~20% of variance in a \>40,000-dimensional dataset.
-   TLS gliomas show widespread transcriptional differences compared with controls.
-   TLS samples have higher immune GEP scores → more active adaptive immune responses.
-   Only 3 GEP genes are individually significant → Coordinated moderate changes rather than strong effects per gene
-   Overall, TLS gliomas have a more active immune microenvironment; GEP scores could potentially help predict response to immunotherapy
-   Limitations: limited sample size, unaccounted confounders (e.g. sex, IDH), and simple linear models
